Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
NAP1L5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
PRSS2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NACC2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LCK - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SCD5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Profile neighbors
FOXG1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GCAT - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TMPRSS15 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PARVB - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LOC101927609 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
OR7E14P - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CHRNA5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MIR6787 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SYNM - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GLDC - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CSF2RB - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DPY19L2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on